(Q33371639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Chronic graft-versus-host disease: Pathogenesis and clinical management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Jose-Antonio Perez-Simon

1 reference

ORCID Public Data File 2021

author name string

José A Pérez-Simón

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ignacio Sánchez-Abarca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Dolores Caballero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Jesús San Miguel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 January 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

1041-1057

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16789791%20AND%20SRC:MED&resulttype=core&format=json

A retrospective study of psychosocial morbidity in bone marrow transplant recipients.

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666080-00002

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666080-00002

Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666080-00002

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666080-00002

Mycophenolate mofetil for the treatment of acute and chronic GVHD is effective and well tolerated but induces a high risk of infectious complications: a series of 21 BM or PBSC transplant patients

21 January 2018

1 reference

12 December 2020

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

12 December 2020

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

12 December 2020

1 reference

12 December 2020

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

1 reference

12 December 2020

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

1 reference

12 December 2020

Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation

1 reference

12 December 2020

Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study

1 reference

12 December 2020

Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation

1 reference

12 December 2020

Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo

1 reference

12 December 2020

Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ

1 reference

12 December 2020

Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response

1 reference

12 December 2020

Immune regulation by regulatory T cells: implications for transplantation

1 reference

12 December 2020

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.

1 reference

12 December 2020

Pathophysiology of acute graft-versus-host disease

1 reference

12 December 2020

Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study

1 reference

12 December 2020

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

1 reference

12 December 2020

L3T4+ T cells induce hepatic lesions resembling primary biliary cirrhosis in mice with graft-versus-host reactions due to major histocompatibility complex class II disparity.

1 reference

12 December 2020

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

1 reference

12 December 2020

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

12 December 2020

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

1 reference

12 December 2020

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

1 reference

12 December 2020

Autoantibodies in chronic GVHD: high prevalence of antinucleolar antibodies

1 reference

12 December 2020

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

1 reference

12 December 2020

Can tolerogenic dendritic cells help to modulate allo-immune responses in the setting of hematopoietic cell transplantation?

1 reference

12 December 2020

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

12 December 2020

Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation

1 reference

12 December 2020

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

1 reference

12 December 2020

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

1 reference

12 December 2020

An old drug for a new disease: pentostatin (Nipent) in acute graft-versus-host disease.

1 reference

12 December 2020

Generation and function of antigen-specific suppressor and regulatory T cells

1 reference

12 December 2020

Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors

1 reference

12 December 2020

Duration of immunosuppressive treatment for chronic graft-versus-host disease

1 reference

12 December 2020

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

1 reference

12 December 2020

Recombinant human tumor necrosis factor receptor fusion protein as complementary treatment for chronic graft-versus-host disease

1 reference

12 December 2020

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

12 December 2020

Treatment of intestinal graft-versus-host disease using betamethasone enemas

1 reference

12 December 2020

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

1 reference

12 December 2020

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

12 December 2020

Preferential activation of Th2 cells in chronic graft-versus-host reaction

1 reference

12 December 2020

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

12 December 2020

Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia

1 reference

12 December 2020

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

12 December 2020

1 reference

12 December 2020

Influence of immunosuppressive drugs on dendritic cells

1 reference

12 December 2020

Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid

1 reference

12 December 2020

Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease

1 reference

12 December 2020

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

1 reference

12 December 2020

Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients

1 reference

12 December 2020

IL-13 production by donor T cells is prognostic of acute graft-versus-host disease following unrelated donor stem cell transplantation

1 reference

12 December 2020

The danger model: a renewed sense of self

1 reference

12 December 2020

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

1 reference

12 December 2020

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

1 reference

12 December 2020

Pathophysiologic mechanisms of acute graft-vs.-host disease

1 reference

12 December 2020

Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of the EORTC-GIMEMA AML 8A trial.

1 reference

12 December 2020

Allotype-specific immunoregulation of autoantibody production by host B cells in chronic graft-versus host disease

1 reference

12 December 2020

Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation

1 reference

12 December 2020

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

12 December 2020

Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype

1 reference

12 December 2020

Nucleolar proteins B23 and C23 as target antigens in chronic graft-versus-host disease

1 reference

12 December 2020

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality

1 reference

12 December 2020

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.

1 reference

12 December 2020

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

12 December 2020

Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance

1 reference

12 December 2020

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

1 reference

12 December 2020

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

1 reference

12 December 2020

Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients

1 reference

12 December 2020

Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

1 reference

12 December 2020

Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia

1 reference

12 December 2020

Cytokine gene expression in mice undergoing chronic graft-versus-host disease

1 reference

12 December 2020

Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease

1 reference

12 December 2020

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

1 reference

12 December 2020

Tolerogenic dendritic cells

1 reference

12 December 2020

Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study

1 reference

12 December 2020

Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD)

1 reference

12 December 2020

Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning.

1 reference

12 December 2020

Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation

1 reference

12 December 2020

Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation

1 reference

12 December 2020

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

1 reference

12 December 2020

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

12 December 2020

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

12 December 2020

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

12 December 2020

Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells

1 reference

12 December 2020

Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease

1 reference

12 December 2020

Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation

1 reference

12 December 2020

Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation.

1 reference

12 December 2020

Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.

1 reference

12 December 2020

Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells

1 reference

12 December 2020

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

1 reference

12 December 2020

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

12 December 2020

Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.

1 reference

12 December 2020

Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation

1 reference

12 December 2020

Development of a prognostic model for grading chronic graft-versus-host disease

1 reference

12 December 2020

Low serum thymic hormone levels in patients with chronic graft-versus-host disease

1 reference

12 December 2020

Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia

1 reference

12 December 2020

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

12 December 2020

In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures

1 reference

12 December 2020

Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.

1 reference

12 December 2020

Pentostatin in steroid-refractory acute graft-versus-host disease

1 reference

12 December 2020

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation

1 reference

12 December 2020

Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms

1 reference

12 December 2020

Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression

1 reference

12 December 2020

Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease

1 reference

12 December 2020

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

12 December 2020

Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease

1 reference

12 December 2020

Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation

1 reference

12 December 2020

National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants

1 reference

12 December 2020

Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood

1 reference

12 December 2020

Consensus among bone marrow transplanters for diagnosis, grading and treatment of chronic graft-versus-host disease. Committee of the International Bone Marrow Transplant Registry

1 reference

12 December 2020

The Pathophysiology of Acute Graft-versus-Host Disease

1 reference

12 December 2020

Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors

1 reference

12 December 2020

High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

1 reference

12 December 2020

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

1 reference

12 December 2020

Quality of life: perceptions of long-term survivors of bone marrow transplantation

1 reference

12 December 2020

Pentostatin for the treatment of chronic graft-versus-host disease in children

1 reference

12 December 2020

Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation.

1 reference

12 December 2020

Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis

1 reference

12 December 2020

Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report.

1 reference

12 December 2020

Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells

1 reference

12 December 2020

Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease

1 reference

12 December 2020

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

12 December 2020

Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation

1 reference

12 December 2020

Thalidomide for treatment of patients with chronic graft-versus-host disease.

1 reference

12 December 2020

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

1 reference

12 December 2020

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

12 December 2020

Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis

1 reference

12 December 2020

How I treat chronic graft-versus-host disease

1 reference

12 December 2020

Acute graft-vs-host disease: pathobiology and management

1 reference

12 December 2020

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

12 December 2020

New approaches for preventing and treating chronic graft-versus-host disease

1 reference

12 December 2020

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

12 December 2020

Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

1 reference

12 December 2020

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

12 December 2020